Combined nicotine replacement therapy (CNRT) and varenicline have been well established as first line options for smoking cessation. But which treatment regimen is best after an initial failure to abstain from smoking?

Lauren Howell, PharmD

Obesity medications such as GLP-1 receptor agonists can help patients lose significant amounts of weight. However, up to half of patients who take a GLP-1 stop taking it after a year, and often regain most of the weight they lost. Now a study published in the March 2024 issue of The Lancet suggests that engaging in supervised exercise while taking a GLP-1 may help patients maintain their weight loss even after they stop taking the medication.

Terri D’Arrigo

Without major reductions in greenhouse gas emissions, the global temperature is projected to rise by up to 2.9° C (5.2° F) by the end of the century. The effects of climate change can already be seen in changing weather patterns, an increase in natural disasters, and exacerbations of existing conditions for those who are most vulnerable.

Sonya Collins

Managing asthma can be a daily challenge for the 300 million people worldwide who suffer from the condition, with everything from air pollution to pet dander contributing to attacks. A study published in the April 2024 issue of the Journal of Allergy and Clinical Immunology: In Practice has shed light on another potential trigger: the regular use of household disinfectants and cleaning products, including green products.

Elizabeth Briand

The long-term use of ß-blockers in patients with acute myocardial infarction (MI) who undergo early coronary angiography and have a preserved left ventricular ejection fraction may not lower the risk of death or a new MI as previously believed, revealed a study published in the April 18, 2024, issue of NEJM.

Lauren Howell, PharmD